31 August - 6 September 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Vitamin D may protect myelin
Vitamin D may have a role in protecting myelin in people with progressive MS according to analysis of data from people on a trial of the drug ibudilast. The analysis found no link between vitamin D levels and EDSS scores, brain volume or new lesions on an MRI scan.
Source: MS News Today
MS Trust link: Vitamin D
Ozanimod trail results
Ozanimod, a potential new treatment for relapsing MS, was better than Avonex in reducing relapses according to newly published trial results. The drug also reduced new MRI lesions and the rate of brain tissue loss but didn't show any significant difference in slowing build-up of disability
Source: National MS Society (USA)
MS Trust link: Ozanimod
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.